XML 19 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk (details) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Derivative [Line Items]          
Financial Derivative, Nonmonetary Notional Amount 297,925,000 359,135,000 297,925,000 359,135,000 389,225,000
Physical Derivative, Nonmonetary Notional Amount 241,150,000 322,675,000 241,150,000 322,675,000 552,500,000
Derivative, Notional Amount $ 10,844,000 $ 17,171,000 $ 10,844,000 $ 17,171,000 $ 15,002,000
Summary of Derivative Instruments [Abstract]          
Cost of sales (58,280,000) (59,142,000) (213,481,000) (201,501,000)  
General Discussion of Derivative Instruments and Hedging Activities [Abstract]          
Changes In Fair Value As Deferred Regulatory Assets Or Liabilities In Percentage     80% or 90%    
Changes In Fair Value Deferred As Income Statement For Contracts Not Qualifying For Hedge Accounting And To Other Comprehensive Income For Contracts Qualifying For Hedge Accounting     10% or 20%    
Oregon PGA Deferral Percentage 90.00%        
Target Hedge Percentage     approximately 75%    
Derivative, Gain on Derivative 4,300,000 1,400,000 12,800,000    
Derivative, Loss on Derivative       4,000,000  
Unrealized Loss On Derivatives 11,300,000   11,300,000    
Derivative Asset, Fair Value, Net 11,500,000 200,000 11,500,000 200,000  
Derivative Liability, Fair Value, Net 800,000 9,700,000 800,000 9,700,000  
Derivative Fair Value Of Derivative Net 10,700,000 9,500,000 10,700,000 9,500,000 4,700,000
Natural Gas Commodity [Member]
         
Summary of Derivative Instruments [Abstract]          
Cost of sales (5,379,000) (16,139,000) 10,533,000 (8,956,000)  
Less:Amounts deferred to regulatory accounts on balance sheet (5,223,000) (16,069,000) 10,652,000 (9,032,000)  
Total gain (loss) in pre-tax earnings (156,000) (70,000) (119,000) 76,000  
Foreign Currency [Member]
         
Summary of Derivative Instruments [Abstract]          
Cost of sales 454,000 (274,000) (179,000) 513,000  
Less:Amounts deferred to regulatory accounts on balance sheet 454,000 (274,000) (179,000) 513,000  
Total gain (loss) in pre-tax earnings $ 0 $ 0 $ 0 $ 0